Skip to search formSkip to main contentSkip to account menu

Poractant alfa 80 MG/ML Intratracheal Suspension [Curosurf]

Known as: Curosurf 80 MG/ML Intratracheal Suspension, PORACTANT ALFA 80 mg in 1 mL ENDOTRACHEAL SUSPENSION [Curosurf] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract Inhaled nanoparticles (NPs) have high-deposition rates in the alveolar region of the lung but the effects of pulmonary… 
2015
2015
Inhaled nanoparticles have a high deposition rate in the alveolar units of the deep lung. The alveolar epithelium is composed of… 
2013
2013
Because of an increasing exposure to environmental and occupational nanoparticles (NPs), the potential risk of these materials… 
2011
2011
BACKGROUND The aerosolization of perfluorocarbons or surfactant has emerged as a feasible alternative to instillation, for the… 
2011
2011
The interfacial properties of tracheal aspirate from infants with untreated neonatal respiratory distress syndrome (NRDS), and… 
2005
2005
Background. Glucocorticoids have been used successfully in the amelioration of chronic lung disease (CLD). Unfortunately, higher…